4 November 2025 | 6:22PM HKT Equity Research Sino Biopharmaceutical (1177.HK): APAC Healthcare Corporate Day 2025 — Key Takeaways: Encouraging product sales growth in 3Q Presenters: Hsin Tse - Executive Director, Senior Vice President Bottom line: Management highlighted an encouraging trend in product sales in 3Q driven by new products, and noted earnings growth could be faster with investment gain. The company still targets to achieve a major BD deal with US$100mn+ upfront payments by YE25. Key Takeaways P ...